West Lafayette, IN, United States of America

Stephen Francis Badylak

This inventor holds 91 USPTO granted patents and 35 published patent applications, plus 2 CIPO patents and 18 EPO patents, primarily in Extracellular Matrix Hydrogels (CPC class A61L27-3633). Top assignees: Purdue Research Foundation, University of Pittsburgh, Methodist Hospital of Indiana, Inc.. Active years: 1990-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Francis Badylak. Retrieved from https://idiyas.com/inventor/stephen-francis-badylak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 91 (Patent Applications = 35)

% Patents Active = 90.1

CIPO Patents = 2 (Patent Applications = 12)

EPO Patents = 18 (Patent Applications = 20)

Average Co-Inventor Count = 2.8

ph-index = 41

Forward Citations = 10,220(Granted Patents)

Forward Citations (Not Self Cited) = 8,585(Dec 10, 2025)

Inventors with similar research interests:

Robert G Matheny

Location History:

W. Lafayette, IN (US) (1994 - 2010)
Pittsburgh, PA (US) (2011 - 2022)
West Lafayette, IN (US) (1990 - 2024)

Company Filing History:

47 out of 2,785

Purdue Research Foundation

patents

40 out of 1,960

University of Pittsburgh

patents

13 out of 26

Methodist Hospital of Indiana, Inc.

patents

4. 6 out of 8

Clarian Health Partners, Inc.

patents

5. 2 out of 104

University of Nottingham

University of Michigan

patents

10. 3 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2026

Loading Chart...

Areas of Expertise:

Hydrogel

Tissue Repair

Biodegradable

Vascularization

Soft Tissue

Scaffold

Inflammation

Gastroesophageal Junction

Matrix Bound Vesicles

Wound Healing

Ocular Applications

Joint Bioscaffolds

91 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12741026 - Microparticle-Assisted Treg Therapy for Treatment of Tissue Injury and Fibrosis (2026-09-22),

2. 12734274 - Methods for preparation of a terminally sterilized hydrogel or colloidal suspension derived from extracellular matrix, and uses thereof (2026-09-15),

3. 12653926 - Extracellular matrix-derived gels and related methods (2026-06-16),

4. 12605489 - Use of a urinary bladder ECM hydrogel as an esophageal submucosal fluid cushion (2026-04-21),

5. 12440444 - Matrix bound vesicles (MBVS) containing IL-33 and their use (2025-10-14),

6. 12383243 - Extracellular matrix (ECM) hydrogel as a submucosal fluid cushion (2025-08-12),

7. 12329883 - Soft tissue repair implants comprising hydroxybutyrate (2025-06-17),

8. 12303533 - ECM hydrogel for treating esophageal inflammation (2025-05-20),

9. 12263270 - Acoustic extracellular matrix hydrogels and their use (2025-04-01),

10. 12201745 - Vascular extracellular matrix hydrogel (2025-01-21),

11. 12161778 - Matrix bound nanovesicles and their use (2024-12-10),

12. 12005158 - Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix (2024-06-11),

13. 11707485 - ECM hydrogel for treating esophageal inflammation (2023-07-25),

14. 11638724 - Ocular applications of matrix bound vesicles (MBVs) (2023-05-02),

15. 11413375 - Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix (2022-08-16),

Title: The Innovative Journey of Stephen Francis Badylak

Introduction: Stephen Francis Badylak is a renowned inventor based in West Lafayette, Indiana. His groundbreaking work in the field of regenerative medicine has revolutionized the medical industry and has earned him global recognition.

Latest Patents: Stephen Francis Badylak holds several patents in the field of regenerative medicine, focusing on tissue engineering and biomaterials. His innovative patents have paved the way for new advancements in medical treatments and therapies.

Career Highlights: With a distinguished career spanning several decades, Stephen Francis Badylak has made significant contributions to the field of regenerative medicine. He has served as a professor at the University of Pittsburgh and has been involved in numerous research projects aimed at developing novel medical solutions.

Collaborations: Throughout his career, Stephen Francis Badylak has collaborated with leading researchers, medical professionals, and industry experts to further the field of regenerative medicine. His collaborative efforts have resulted in groundbreaking discoveries and innovative solutions for complex medical challenges.

Conclusion: Stephen Francis Badylak's dedication to advancing regenerative medicine through innovation and collaboration has had a profound impact on the medical field. His pioneering work continues to inspire new generations of inventors and researchers to push the boundaries of what is possible in healthcare.

Profile summary based on public USPTO records.